On February 22, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar on two draft guidance documents for the transition plans for medical devices commercialized pursuant to either ...
These policies are all currently set to expire on November 7, 2023, which is 180 days after May 11, 2023. The Enforcement Policy Transition Guidance sets out three phases: Phase 1 (first 90 days after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results